Company Profile
Company Overview
Tricida, Inc., is a privately-held, clinical stage, biopharmaceutical company focused on the discovery and development of non-absorbed therapies. Tricida’s lead investigational drug candidate, TRC101, represents a first-in-class approach to the treatment of metabolic acidosis, a common complication of chronic kidney disease (CKD) that can result in increased mortality, accelerated progression of kidney disease, progressive muscle breakdown and exacerbation of bone disease.
In January of 2016, the FDA accepted Tricida’s Investigational New Drug (IND) application for TRC101 and the company has successfully completed its Phase 1/2 program. The company is now moving into later stage clinical trials.
Tricida is led by a management team with an accomplished and proven track record in discovering and developing new therapeutics, with extensive experience in building successful companies around strong science and unmet medical needs. The Company is backed by world-class venture capital firms.
Tricida’s shared culture of teamwork, camaraderie and empowerment is evident in the dedication and focus our employees demonstrate, with a commitment to the ultimate goal of improving and prolonging the lives of people living with CKD. If you share our passion and are dedicated to building a company centered on cutting-edge science that delivers new innovations to patients, then we would like to speak with you. We seek talented and high-achieving professionals to join us as we work towards bringing critically needed new therapies to patients.
www.tricida.com
Benefits
Competitive Compensation and Benefits include: Medical, Dental, and Vision Coverages, Life, AD&D, Disability, 401(k), Flexible Spending Plan, and Pre-IPO stock options. 15 vacation days per year and 11 paid holidays per year, which includes 1 floating holiday. Daily lunch provided and many other employee perks.